WAM
THC icon

Wakefield Asset Management’s Tenet Healthcare THC Stock Holding History

Wakefield Asset Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.95M Buy
21,108
+219
+1% +$40.3K 0.89% 32
2026
Q1 		$3.94M Buy
20,889
+21
+0.1% +$4.42K 1.04% 30
2025
Q4 		$4.15M Sell
20,868
-275
-1% -$55.6K 1.12% 22
2025
Q3 		$4.29M Sell
21,143
-4,611
-18% -$818K 1.17% 19
2025
Q2 		$4.53M Sell
25,754
-1,174
-4% -$177K 1.27% 13
2025
Q1 		$3.62M Buy
26,928
+1,477
+6% +$195K 1.1% 20
2024
Q4 		$3.21M Sell
25,451
-313
-1% -$46.5K 1.08% 38
2024
Q3 		$4.28M Buy
25,764
+178
+0.7% +$26.9K 1.39% 17
2024
Q2 		$3.4M Buy
+25,586
New +$3.08M 1.19% 27
2022
Q4 		– Sell
-10,391
Closed -$536K – 183
2022
Q3 		$536K Buy
10,391
+6
+0.1% +$356 0.25% 121
2022
Q2 		$546K Buy
10,385
+12
+0.1% +$835 0.23% 123
2022
Q1 		$892K Sell
10,373
-2,476
-19% -$203K 0.32% 91
2021
Q4 		$1.05M Buy
12,849
+106
+0.8% +$7.75K 0.36% 79
2021
Q3 		$847K Sell
12,743
-261
-2% -$18.5K 0.32% 90
2021
Q2 		$871K Sell
13,004
-3,257
-20% -$202K 0.33% 94
2021
Q1 		$846K Sell
16,261
-458
-3% -$23.2K 0.34% 84
2020
Q4 		$668K Buy
+16,719
New +$540K 0.28% 107
2020
Q2 		– Sell
-20,623
Closed -$297K – 209
2020
Q1 		$297K Buy
20,623
+2,705
+15% +$77.6K 0.16% 128
2019
Q4 		$681K Sell
17,918
-273
-2% -$8.18K 0.28% 85
2019
Q3 		$402K Buy
18,191
+411
+2% +$8.76K 0.18% 131
2019
Q2 		$367K Sell
17,780
-1,235
-6% -$28.5K 0.15% 135
2019
Q1 		$548K Buy
+19,015
New +$469K 0.2% 120

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Wakefield Asset Management's THC Position: Q2 2026 in Review

Wakefield Asset Management increased its Tenet Healthcare (THC) stake by 1% in Q2 2026, buying an estimated $40.3K and bringing the position to 21,108 shares worth $3.95M. The position accounts for 0.89% of the portfolio, ranked #32.

Wakefield Asset Management first reported a position in THC in Q1 2019 and has held it in 22 quarters since. The position peaked at $4.53M in Q2 2025. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Wakefield Asset Management held 21,108 shares of Tenet Healthcare worth $3.95M as of Q2 2026.
  • Wakefield Asset Management bought 219 Tenet Healthcare shares in Q2 2026, an estimated $40.3K.
  • Tenet Healthcare made up 0.89% of Wakefield Asset Management's portfolio in Q2 2026, its #32 holding.
  • Wakefield Asset Management first reported a position in Tenet Healthcare in Q1 2019 and has held it in 22 quarters since.
  • Wakefield Asset Management's Tenet Healthcare position peaked at $4.53M in Q2 2025.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Wakefield Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.